Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not [NA]

View source ↗

Summary

This clinical trial in pancreatic neuroendocrine tumor is evaluating whether optimal surgical debulking provides benefit. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Uppsala University | Conditions: Pancreatic Neuroendocrine Tumor | NA | Status: RECRUITING